Unbound MEDLINE

Antibody-mediated rejection following transplantation from an HLA-identical sibling. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association [Nephrol Dial Transplant] Journal article

 
TitleAntibody-mediated rejection following transplantation from an HLA-identical sibling.
Author(s)Grafft CA, Cornell LD, Gloor JM, Cosio FG, Gandhi MJ, Dean PG, Stegall MD, Amer H 
Institution1Division of Nephrology and Hypertension, Department of Internal Medicine.
SourceNephrol Dial Transplant 2009 Oct 20.
AbstractPutative antibody-mediated rejection (AMR) in HLA-identical sibling transplantation has rarely been reported and occurred before routine calcineurin inhibitor use. A 29-year-old male developed allograft dysfunction following an HLA-identical renal transplant from his sibling. A pretransplant panel-reactive antibody (PRA) was elevated, pre-transplant crossmatch was negative and no donor-specific antibody (DSA) was identified. Induction with alemtuzumab was followed by maintenance immunosuppression with corticosteroids, tacrolimus and mycophenolate. A biopsy for allograft dysfunction suggested AMR, but DSA could not be detected. Treatment for rejection was transiently successful. Undetectable minor histocompatibility antibodies may have contributed.
LanguageENG
Pub Type(s)JOURNAL ARTICLE
PubMed ID19846396
  
Advertise on this site.